Viewing Study NCT06645002



Ignite Creation Date: 2024-10-26 @ 3:43 PM
Last Modification Date: 2024-10-26 @ 3:43 PM
Study NCT ID: NCT06645002
Status: ENROLLING_BY_INVITATION
Last Update Posted: None
First Post: 2024-09-27

Brief Title: Effect of Stevia Leave Powder on Blood Glucose and Lipid Profile of Diabetic Patients
Sponsor: None
Organization: None

Study Overview

Official Title: Effect of Short and Long-Term Treatment of Stevia Leave Powder on Blood Glucose and Lipid Profile of Diabetic Patients
Status: ENROLLING_BY_INVITATION
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Diabetes
Brief Summary: The goal of this clinical trial is to know if stevia leave powder capsule 1000 mgday will work to treat diabetes in participants The main objectives it aims to answer are

Does stevia decrease the blood glucose level in diabetic subjects that will use stevia powder capsule Does stevia play its role in blood lipid profile in diabetic subjects that will use stevia powder capsule The purpose of the study to see the impact of stevia in short 7 days and long-term treatments 60 days in diabetic subjects and compare the results

Diabetic subjects will

Take stevia powder capsule every day for 7 days in short term study Take stevia powder capsule every day for 60 days in long term study

Check the biochemical assessment including blood glucose and lipid profile tests at 0 and 7th days in short term study Check the biochemical assessment including blood glucose and lipid profile tests at 0 and 30 and 60th days in long term study Keep a record of all the tests for comparison
Detailed Description: The selected participants will be randomly divided into placebo and treatment groups The Initial 0-Day data on anthropometric measurements and blood analysis on glucose lipid levels and liver function tests LFTs will be carried out

The balance diet plan will be prepared according to Pakistan dietary guidelines and given to all the study participants Treatment stevia powder capsules will be provided to the participants for 7 days and for 60 days for short and long-term study respectively for monitoring of compliance Anthropometric measurements and biochemical assessments like blood glucose levels lipid profile insulin resistance and LFTs for short-term study will be measured at baseline 7th and 60th day while measurements of blood glucose lipid profile insulin resistance and LFTs will be carried out a baseline 30 and 60 days for long-term study In this research we will be analysed the effect of stevia powder capsules on diabetic patients for short and long term study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None